When All Other Treatments Fail, the SynCardia Total Artificial Heart Can Save the Sickest of the Sick. The Freedom Portable Driver Allows a Majority of SynCardia Patients to be Discharged from the Hospital to Live at Home & Get In Better Shape for Their Heart Transplant.
TUCSON, Ariz. – May 20, 2014 – SynCardia Systems, Inc. announced today that a United States patient with end-stage biventricular heart failure received the 1,300th implant of the SynCardia temporary Total Artificial Heart as a bridge to transplant in April 2014.
“The SynCardia Heart saves patients dying of end-stage biventricular (both sides) heart failure and the Freedom® portable driver provides patients without human hearts a life worth living outside the hospital,” says Michael P. Garippa, SynCardia CEO and President. “Discharge on the 13.5-pound Freedom portable driver improves the patient’s quality of life with nearly unlimited mobility while eliminating most in-hospital costs for this portion of their care.”
According to the New England Journal of Medicine
(N Engl J Med 2004;351:859-67), Total Artificial Heart patients have the highest bridge to transplant rate of any approved device, 79%. During the last 24 months there have been over 300 implants of the SynCardia Heart.
Similar to a heart transplant, the SynCardia Total Artificial Heart replaces the two failing ventricles and four heart valves. It is the only device that eliminates the source and symptoms of end-stage heart failure…
Read More
The SynCardia temporary Total Artificial Heart is approved for use as a bridge to transplant in cardiac transplant-eligible candidates at risk of imminent death from biventricular failure.
Visit SynCardia’s website for:
- NEW Medical Professionals Videos
- Humanitarian Use Device (HUD) Designations: 70cc & 50cc
- Request Brochures
- Freedom® Portable Driver
- Companion 2 Hospital Driver
- Awards & Recognition
World’s first and only approved Total Artificial Heart
1,300+ implants account for nearly 400 patient years of support
ContactL Don Isaacs • 520-955-0660 • disaacs@syncardia.com